In 2022, researchers revealed that, prior to overt peripheral lupus pathology, lupus mice exhibited persistent phagocytic microglial reactivation and significant anxiety-like behavioral patterns, and neuronal restoration of Nr4a1 or antibody inhibition of C1q improved neuropsychiatric manifestations [13]. Here, NR4A1 is linked to systemic lupus erythematosus.